This observation is consistent with a previous study showing similar effects of PDK1 inhibitors BX-912 and AR-12 in myeloma cells, with IC50 ranging from 2.5 to 12.8 μM [17]. This evidence concerns the gene PDK1 and plasma cell myeloma.